News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,899 Results
Type
Article (45672)
Company Profile (474)
Press Release (696741)
Multimedia
Podcasts (128)
Webinars (20)
Section
Business (209999)
Career Advice (2542)
Deals (36281)
Drug Delivery (123)
Drug Development (84340)
Employer Resources (177)
FDA (16758)
Job Trends (15302)
News (355863)
Policy (33546)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2698)
Accelerated approval (36)
Adcomms (29)
Allergies (147)
Alliances (51254)
ALS (180)
Alzheimer's disease (1736)
Antibody-drug conjugate (ADC) (331)
Approvals (16987)
Artificial intelligence (550)
Autoimmune disease (161)
Automation (39)
Bankruptcy (375)
Best Places to Work (11903)
BIOSECURE Act (20)
Biosimilars (194)
Biotechnology (331)
Bladder cancer (162)
Brain cancer (60)
Breast cancer (655)
Cancer (4962)
Cardiovascular disease (420)
Career advice (2149)
Career pathing (40)
CAR-T (295)
CDC (47)
Celiac Disease (2)
Cell therapy (787)
Cervical cancer (36)
Clinical research (71701)
Collaboration (1805)
Company closure (4)
Compensation (1185)
Complete response letters (67)
COVID-19 (2819)
CRISPR (100)
C-suite (889)
Cystic fibrosis (153)
Data (6336)
Decentralized trials (2)
Denatured (39)
Depression (144)
Diabetes (508)
Diagnostics (6776)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (271)
Drug pricing (201)
Drug shortages (30)
Duchenne muscular dystrophy (245)
Earnings (91592)
Editorial (62)
Employer branding (22)
Employer resources (156)
Events (121287)
Executive appointments (1009)
FDA (19918)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1537)
Gene editing (216)
Generative AI (45)
Gene therapy (652)
GLP-1 (1042)
Government (4815)
Grass and pollen (6)
Guidances (384)
Healthcare (19336)
HIV (60)
Huntington's disease (47)
IgA nephropathy (87)
Immunology and inflammation (275)
Immuno-oncology (62)
Indications (111)
Infectious disease (3097)
Inflammatory bowel disease (200)
Inflation Reduction Act (17)
Influenza (119)
Intellectual property (254)
Interviews (465)
IPO (16974)
IRA (53)
Job creations (3763)
Job search strategy (1773)
JPM (67)
Kidney cancer (16)
Labor market (86)
Layoffs (588)
Leadership (35)
Legal (8088)
Liver cancer (95)
Longevity (14)
Lung cancer (671)
Lymphoma (382)
Machine learning (43)
Management (59)
Manufacturing (819)
MASH (171)
Medical device (13964)
Medtech (14017)
Mergers & acquisitions (20388)
Metabolic disorders (1336)
Multiple sclerosis (165)
NASH (19)
Neurodegenerative disease (343)
Neuropsychiatric disorders (97)
Neuroscience (3041)
Neurotech (1)
NextGen: Class of 2026 (6864)
Non-profit (4660)
Now hiring (68)
Obesity (644)
Opinion (301)
Ovarian cancer (168)
Pain (208)
Pancreatic cancer (233)
Parkinson's disease (296)
Partnered (34)
Patents (500)
Patient recruitment (504)
Peanut (58)
People (60575)
Pharmaceutical (86)
Pharmacy benefit managers (30)
Phase 1 (22533)
Phase 2 (31599)
Phase 3 (23396)
Pipeline (5365)
Policy (301)
Postmarket research (2622)
Preclinical (9644)
Press Release (67)
Prostate cancer (247)
Psychedelics (56)
Radiopharmaceuticals (298)
Rare diseases (901)
Real estate (6106)
Recruiting (73)
Regulatory (25192)
Reports (53)
Research institute (2510)
Resumes & cover letters (409)
Rett syndrome (27)
RNA editing (21)
RSV (78)
Schizophrenia (156)
Series A (255)
Series B (202)
Service/supplier (11)
Sickle cell disease (105)
Special edition (27)
Spinal muscular atrophy (162)
Sponsored (43)
Startups (3824)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (90)
The Weekly (87)
Vaccines (1052)
Venture capital (95)
Weight loss (421)
Women's health (93)
Worklife (20)
Date
Today (29)
Last 7 days (573)
Last 30 days (2107)
Last 365 days (30733)
2026 (3589)
2025 (31103)
2024 (36378)
2023 (41107)
2022 (52385)
2021 (56911)
2020 (55111)
2019 (47750)
2018 (36013)
2017 (33259)
2016 (32661)
2015 (38674)
2014 (32426)
2013 (27384)
2012 (29478)
2011 (30128)
2010 (28244)
Location
Africa (826)
Alabama (89)
Alaska (7)
Arizona (319)
Arkansas (14)
Asia (41054)
Australia (6886)
California (11520)
Canada (3315)
China (1147)
Colorado (487)
Connecticut (497)
Delaware (339)
Europe (90261)
Florida (1700)
Georgia (361)
Hawaii (3)
Idaho (62)
Illinois (888)
India (67)
Indiana (527)
Iowa (24)
Japan (439)
Kansas (130)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1410)
Massachusetts (8376)
Michigan (327)
Minnesota (641)
Mississippi (5)
Missouri (130)
Montana (34)
Nebraska (28)
Nevada (122)
New Hampshire (83)
New Jersey (3067)
New Mexico (31)
New York (3025)
North Carolina (1537)
North Dakota (9)
Northern California (5607)
Ohio (338)
Oklahoma (21)
Oregon (45)
Pennsylvania (2307)
Puerto Rico (24)
Rhode Island (49)
South America (1192)
South Carolina (66)
South Dakota (1)
Southern California (4467)
Tennessee (175)
Texas (1771)
United States (40990)
Utah (341)
Vermont (1)
Virginia (268)
Washington D.C. (82)
Washington State (956)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
742,899 Results for "good therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Novo’s Wegovy Pill Success Is ‘Good News’ for Orforglipron, Lilly Execs Say
Novo Nordisk and Eli Lilly both think the Wegovy pill is doing well, but the American rival sees the successful launch as a harbinger of good news for its own candidate, orforglipron, which is expected to hit the market in the second quarter.
February 4, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
bioLytical’s iStatis Syphilis Antibody Test Now Included in the Australian Register of Therapeutic Goods (ARTG)
October 13, 2025
·
4 min read
Artificial intelligence
Roche Makes Good on Dealmaking Promise With $1.1B Caris Cancer Collab
Roche CEO Thomas Schinecker said during the company’s Q3 call that it is “not done” with deals—a promise he delivered on with Tuesday’s solid tumor pact with AI-focused Caris Life Sciences.
December 17, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Opus Genetics Featured on Good Morning America Spotlighting Breakthrough Gene Therapy Restoring Sight in Patients with Inherited Blindness
November 4, 2025
·
4 min read
Diabetes
Lilly’s Mounjaro ‘Good Enough’ in Cardio Trial, Will Seek Expanded Approval
While Eli Lilly’s diabetes blockbuster was non-inferior to its older incretin therapy Trulicity in a highly anticipated Phase III cardiovascular outcomes trial, analysts had hoped for statistical significance in reducing major events such as cardiovascular death, heart attack and stroke.
July 31, 2025
·
2 min read
·
Heather McKenzie
Press Releases
TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida
New facility increases output, reduces cost of goods sold (COGS) and enhances service for B2B customers to address the forecasted increased demand for products
December 17, 2025
·
5 min read
Press Releases
Sale of Intellectual Property – Mythic Therapeutics Inc.
December 23, 2025
·
1 min read
Regulatory
HHS Backs Prasad Amid Moderna Flu Shot Blowback
An unnamed FDA official also told reporters that it would be good for Moderna to “show some humility” and admit that it didn’t follow the regulator’s recommendations in testing its mRNA flu vaccine.
February 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO® (copper histidinate)
January 13, 2026
·
9 min read
Press Releases
Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
February 12, 2026
·
6 min read
1 of 74,290
Next
